摘要
背景:先兆子痫是以高血压和蛋白尿为特征的二十周妊娠特征的妊娠疾病,是造成胎儿和孕产妇死亡的主要原因之一。虽然发现多种遗传和环境因素与先兆子痫风险有关,但致病途径仍未明确定义。 通过在怀孕期间进行障碍,胎儿 - 母亲交换和内分泌功能,胎盘在胎儿发育中发挥关键作用。 累积数据表明,多个长的非编码RNA(LncRNA)的表达在先兆子痫胎盘中失调。 此外,LncRNA表达的操作导致滋养层细胞培养物的功能改变,包括增殖,分化,凋亡和迁移的变化。 目的:本文回顾了关于这一主题的公布数据,并提供了有关胎盘滋养层细胞中LncRNA IGF2 / H19,MEG3,SPRY4-IT1,HOTAIR,MALAT1,FLT1P1和CEACAMP8的调节和功能的详细信息。 还讨论了这些LncRNA作用的潜在机制,以便于更好地了解这些LncRNA对先兆子痫发病机制的潜在作用。结论:阐述了一些lncRNA可能通过甲基化,Notch-EGFL7信号通路和Wnt /β-连环蛋白途径促进先兆子痫的发病机制。
关键词: 先兆子痫,非编码RNA,LncRNA,滋养层,胎盘,发病机制
Current Drug Targets
Title:Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Volume: 18 Issue: 10
关键词: 先兆子痫,非编码RNA,LncRNA,滋养层,胎盘,发病机制
摘要: Background: Preeclampsia, a gestational disease characterized by hypertension and proteinuria twenty weeks into pregnancy, is one of the leading causes of fetal and maternal mortality. Although multiple genetic and environmental factors are found to be related to the preeclampsia risk, the pathogenic pathways remain largely undefined. The placenta plays a critical role in the fetal development by carrying out the barrier, fetal-maternal exchange, and endocrine functions during pregnancy. Accumulated data indicated that the expression of multiple long noncoding RNA (LncRNA) is dysregulated in preeclamptic placentas. Moreover, manipulation of LncRNA expression led to functional alterations in trophoblast cell cultures, including changes in proliferation, differentiation, apoptosis, and migration.
Objective: This article reviews published data on this subject and provides detailed information on the regulation and function of LncRNAs IGF2/H19, MEG3, SPRY4-IT1, HOTAIR, MALAT1, and FLT1P1 and CEACAMP8 in placental trophoblasts. The potential mechanisms underlying the action of these LncRNAs are also discussed to facilitate a better understanding on the potential role of these LncRNAs for the pathogenesis of preeclampsia. Conclusion: It is elaborated that some lncRNAs probably contribute to the pathogenesis of preeclampsia through methylation, Notch-EGFL7 signaling pathway and Wnt/β-catenin pathway.Export Options
About this article
Cite this article as:
Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia, Current Drug Targets 2017; 18 (10) . https://dx.doi.org/10.2174/1389450118666170404160000
DOI https://dx.doi.org/10.2174/1389450118666170404160000 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vascular Effects of Phytoestrogens and Alternative Menopausal Hormone Therapy in Cardiovascular Disease
Mini-Reviews in Medicinal Chemistry Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Impact of Hyperhomocyst(e)inemia on Endothelial Function
Vascular Disease Prevention (Discontinued) Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf
Current Vascular Pharmacology Risk Factors and Mediators of the Vascular Dysfunction Associated with Hypertension in Pregnancy
Cardiovascular & Hematological Disorders-Drug Targets Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)
CNS & Neurological Disorders - Drug Targets Medicinal Plants with Multiple Effects on Cardiovascular Diseases: A Systematic Review
Current Pharmaceutical Design Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension
Current Vascular Pharmacology Comparative Efficacy and Safety Study of Darbepoetin Alfa <i>versus</i> Epoetin Alfa in Management of Anemia Associated with ESRD in Egyptian Hemodialysis Patients
Current Drug Safety Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology Prediction of Bioactive Peptides from Chicken Feather and Pig Hair Keratins using <i>In Silico</i> Analysis Based on Fragmentomic Approach
Current Pharmaceutical Design Ezetimibe and Vascular Inflammation
Current Vascular Pharmacology Oxidative Stress on Progenitor and Stem Cells in Cardiovascular Diseases
Current Pharmaceutical Biotechnology Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
Current Pharmaceutical Design Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews The Anti-Atherogenic Effects of Thiazolidinediones
Current Diabetes Reviews The Evaluation and Utilization of Marine-derived Bioactive Compounds with Anti-obesity Effect
Current Medicinal Chemistry Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism Impact of Stroke Severity on the Smoking Paradox in Patients Treated with Intravenous Thrombolysis
Current Neurovascular Research Subject Index To Volume 4
Cardiovascular & Hematological Agents in Medicinal Chemistry